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In the semi-darkness of the evening a professor walks 
in the wood. He sees a bird. It flies like a duck. It swims 
like a duck. It quacks like a duck. Back at home he tells 
his children: “I saw a duck!”.
Later that same evening the professor settles down to 
write a paper on a case study of a telehealth innova-
tion he has been investigating—one that provided a 
device to patients with chronic obstructive pulmonary 
disease (COPD) so that professionals could monitor 
and  manage  patient  care  remotely,  and  one  where 
patients  could  manage  care  better  by  themselves. 
The  results  seemed  promising:  patients  and  carers 
were enthusiastic; self-reported health outcomes had 
improved; professionals supporting the delivery of the 
innovation were highly satisfied and felt care was pro-
vided in a more integrated way; and hospital admis-
sions and lengths of stay per patient enrolled in the 
study had decreased compared to previous levels. The 
professor concluded that the innovation was a great 
success and that the deployment of new technologies 
had significant promise in delivering more cost-effec-
tive care to people with COPD.
On publication of the professor’s research his critics hit 
back. To them, it was unclear from the professor’s study 
whether the telehealth intervention reduced overall costs 
to the local health system. They pointed out that COPD-
related admissions to the local hospital continued to rise 
at the same rate, suggesting that the interventions were 
targeted  at  the  wrong  people.  They  queried  whether 
it was really the technology that was important since 
patients  received  active  nurse-led  case  management 
alongside  it  which  they  had  not  benefited  from  previ-
ously. They thought the sample size was too small to be 
meaningful. They concluded the research was flawed, 
could not be applied to other settings, and should not 
be included as ‘high-level’ evidence to influence whether 
telehealth solutions should be adopted more widely.
Lack of robust evidence is often cited in telehealth as 
a barrier to adoption, as it is with many integrated care 
innovations more generally. In our hypothetical exam-
ple, the level of uncertainty in the professor’s observa-
tions provided the excuse needed to ignore his results, 
rather than to take on board the positive noises being 
produced. It is as if his children had said, disbeliev-
ingly, “Are you sure what you saw was a duck? It was 
very dark outside. I think you may have seen that small 
swan that we saw last week, or even that strange bird 
that visits our tree-house!” Without a sound method-
ology, results and observations are open to different 
interpretations.
The question we pose in this editorial is what level of 
evidence is good enough to provide a convincing case 
for adoption of, in this case, telehealth? This question 
lay at the heart of discussions at the recent Interna-
tional Congress on Telehealth and Telecare, streamed 
live from The King’s Fund in London to over 2000 peo-
ple from 60 countries (proceedings will be published 
in a forthcoming IJIC conference supplement, but the 
debates  can  be  revisited  at:  www.kingsfund.tv/tele-
health).
This international congress was built around the early 
findings from the UK Department of Health’s Whole 
System  Demonstrator  (WSD)  Pilot  Programme—the 
largest cluster randomised control trial (RCT) of tele-
health ever conceived. The field trial was established 
to provide a ‘proof of concept’ on the legitimacy of tele-
health as a way of caring for patients with chronic illness. 
Established in early 2009, the trial has involved more 
than 6000 patients with heart failure, COPD or diabetes 
whom were randomly allocated to either an experimen-
tal group or care-as-usual group. The complex study 
design sought to examine cost-effectiveness, changes 
in utilisation of care facilities, health outcomes, impact 
on carer burden, utility of the technology from a patient 
and professional point of view, plus issues related to 
organisational development. To account for local con-
text, the trial was further sub-divided across three dif-
ferent localities—Cornwall (rural), Kent (suburban and 
wealthy), and Newham (a deprived and multi-ethnic 
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inner-city London borough). The overall cost of the trial 
was reported to be £31 million sterling of which about 
12% was allocated to the evaluation itself.
Those working in delivering care during the trial were 
positive in their feedback at the conference. Positive 
experiences from patients, carers, nurses and family 
practitioners were reported in Newham. In Cornwall, it 
was reported how the technology worked safely, pro-
tected privacy and had developed good interoperabil-
ity between the different e-health applications and data 
sets required. In Kent, local evaluations concluded the 
scheme to be cost-effective and especially beneficial 
in relieving the burden on carers. Results presented 
by  the  Department  of  Health  reported  ‘encouraging’ 
early findings, including (unspecified) reduced hospi-
tal admissions for people with COPD and a ‘positive’ 
impact on system cost-effectiveness.
However, amongst the attending delegates and those 
watching  remotely,  there  was  considerable  doubt  as 
to the overall value of RCTs. First, as proven in the 
UK context, they are expensive and time-consuming. 
Second, RCTs remain contextually-specific and prob-
lematic  to  generalise  their  findings  in  other  regions 
and  countries. Third,  new  assistive  technologies  are 
emerging rapidly meaning that current evaluations will 
soon be out-of-date since the future format of care will 
change; for example, through the use of social media, 
mobile phones, remote sensors, and ingestible moni-
toring devices. Large academic studies take 3–5 years 
to complete from formulation of a research question to 
publication in an academic journal; and then even lon-
ger for them to become adopted in practice (if at all). 
Such a glacial process in the production and adoption 
of ‘high quality’ evidence simply does not fit well in the 
innovative and fast changing field of telehealth.
During the debate at the conference it was argued that 
evidence was essential, but that this should not get in the 
way of promoting technological innovation and invest-
ing in the necessary redesign of care services. Ideally, it 
was argued, research and service innovation should run 
conjointly as party of a continuous process of innovation 
and improvement. But how could this be achieved?
In an attempt to solve this problem on the utility of 
research  findings,  the  Danish  Health  Technology 
Assessment  (HTA)  researcher  Kristian  Kidholm  pre-
sented  to  the  conference  a  new  research  model  to 
evaluate telemedicine innovations (MAST, accessible 
at http://www.mast-model.info). The purpose of MAST 
has been to provide a structured framework for assess-
ing the effectiveness and contribution to quality of care 
of telemedicine applications, based on users need for 
information as a basis for decision-making. The evalu-
ation methodology promotes a ‘transferability assess-
ment’ based on seven standard questions to ensure 
for comparability in the design of research. It also pro-
vides a platform through which to enable routine out-
come monitoring (‘romming’) that allows real-time data 
to be collected, aggregated, continuously statistically 
analysed, and reported over time to evaluators and 
decision-makers alike. Such an approach is currently 
popular in the Dutch mental health services (see www.
routine-outcome-monitoring.nl).
The conclusion we reach is that research and evaluation 
needs to be much more closely aligned with innovators 
and decision-makers to enable them to utilise the best 
available evidence in ‘real-time’. However, traditional 
research and evaluation studies are not conducted to 
facilitate such rapid knowledge-transfer. In particular, 
the adoption of new technologies is a fast-moving area 
that cannot sit back and wait for the evidence as tradi-
tionally gathered. New methodologies and approaches 
are needed and this will only come to fruition through 
better cooperation between scientists, professionals, 
product developers, and policy-makers.
As a scientific journal dedicated to the promotion of 
innovative methods, research papers and case stud-
ies of approaches to integrated care such as telehealth 
we invite readers with expertise in this field to submit 
articles and to stimulate debate. As an e-based jour-
nal, submissions are accepted at all times and are peer 
reviewed and published on a continuous basis. This 
means that your work does not lie on a shelf waiting for 
publication since this is guaranteed between three and 
eight weeks after acceptance.
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